Evidence map›Paper›PMID 26075898›Full record

ArticlePloS one2015

KLF4 Promotes Angiogenesis by Activating VEGF Signaling in Human Retinal Microvascular Endothelial Cells.

Yinan Wang, Chuanhe Yang, Qingqing Gu, Michelle Sims, Weiwang Gu, Lawrence M Pfeffer, Junming Yue

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Yinan WangDepartment of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America; Center for Cancer Research, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America; Department of Laboratory Animal Center, Southern Medical University, Guangzhou, P. R. China.
Chuanhe YangDepartment of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America; Center for Cancer Research, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
Qingqing GuDepartment of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America; Center for Cancer Research, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
Michelle SimsDepartment of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America; Center for Cancer Research, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
Weiwang GuDepartment of Laboratory Animal Center, Southern Medical University, Guangzhou, P. R. China.
Lawrence M PfefferDepartment of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America; Center for Cancer Research, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
Junming YueDepartment of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America; Center for Cancer Research, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
University of Tennessee Health Science Center · USCenter for Cancer Research · USSouthern Medical University · CN

Funding

Transgenic rat overexpressing miR-21 in vascular smooth muscle cells:functional iR21HL095957 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI YUE, JUNMING · 2010 to 2011
$421k
NHLBI NIH HHS HL095957NHLBI NIH HHS R21 HL095957
6 · The paper itself

Abstract

The transcription factor Krüppel-like factor 4 (KLF4) has been implicated in regulating cell proliferation, migration and differentiation in a variety of human cells and is one of four factors required for the induction of pluripotent stem cell reprogramming. However, its role has not been addressed in ocular neovascular diseases. This study investigated the role of KLF4 in angiogenesis and underlying molecular mechanisms in human retinal microvascular endothelial cells (HRMECs). The functional role of KLF4 in HRMECs was determined following lentiviral vector mediated inducible expression and shRNA knockdown of KLF4. Inducible expression of KLF4 promotes cell proliferation, migration and tube formation. In contrast, silencing KLF4 inhibits cell proliferation, migration, tube formation and induces apoptosis in HRMECs. KLF4 promotes angiogenesis by transcriptionally activating VEGF expression, thus activating the VEGF signaling pathway in HRMECs.

Indexed as

ApoptosisCell MovementCell ProliferationCells, CulturedEndothelial CellsHumansKruppel-Like Factor 4Kruppel-Like Transcription FactorsNeovascularization, PhysiologicRetinaRetinal VesselsRNA InterferenceRNA, Small InterferingSignal TransductionTranscriptional ActivationVascular Endothelial Growth Factor AKLF4 protein, humanKruppel-Like Factor 4Kruppel-Like Transcription FactorsRNA, Small InterferingVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID26075898
PMCPMC4467843
OpenAlexW2096063383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.